Skip to main content
All articles

Site Operations

Budgeting long-term record storage: the line item sites discover at closeout

By Julio G. Martinez-Clark Published November 17, 2026 Updated November 17, 2026 5 min read

Why storage gets missed

Most site budgets are built around visits. Screening, randomization, follow-up, and closeout each have a price, so they get a line. Storage has no visit attached to it. The work happens quietly after the last participant leaves: boxes or files are retained, access is controlled, retrieval requests are answered, and the clock keeps running for years.

Because no single visit triggers it, storage is often folded into a general closeout fee or left out entirely. That works until the retention period turns out to be longer than anyone assumed, the volume is larger than the estimate, or an extension adds years that were never priced. At that point the site is carrying a real cost with no budget line to charge it to.

Separate physical from electronic

Physical and electronic storage do not cost the same, and they should not share one line.

  • Physical storage: boxes, secure space, environmental controls, inventory, and retrieval and re-filing when a monitor, auditor, or sponsor asks for a record.
  • Electronic storage: the electronic investigator site file (eISF), electronic source records, backups, access controls, and the system cost of keeping records readable and retrievable for the full retention period.

Pricing them separately forces an honest estimate of each. A study with mostly electronic records and a small physical archive should not be priced the same as a paper-heavy study, and a sponsor can approve a split line more easily because it can see what it is paying for.

Agree the retention period before signing

The retention period is the number that drives everything else, and it should be agreed in writing before the budget is signed — tied to the protocol and the sponsor's requirement, not discovered at closeout.

That agreement should name three things: how long records will be retained, what happens at the end of that period (return, transfer, or destruction, and who authorizes it), and what happens if the period is extended. When those three points are in the contract or the budget exhibit, an extension is an administrative step. When they are not, an extension is a new negotiation with no leverage left.

Regulatory expectations, including those of the United States Food and Drug Administration (FDA), set a floor for retention, but the sponsor's own requirement is often longer. Price to the longer of the two, and say so in the budget notes, so there is no argument later about which clock applied.

Price it per year, not as a lump sum

An annual storage fee, charged per year of retention, is easier for both sides than a single lump sum at closeout.

For the site, it matches revenue to the years the cost is actually carried. For the sponsor, it makes extensions simple: if retention runs one more year, one more annual fee applies, at a rate already agreed. A lump sum does the opposite — it invites a dispute about whether extra years were included, and it leaves the site absorbing every year beyond the estimate.

The annual fee should also cover retrieval. Occasional retrieval for monitoring, audit, or inspection is part of storage, not a surprise extra. Name a reasonable retrieval scope in the line, and price work beyond that scope separately, so neither side is surprised.

What to check at your next budget

Before signing your next budget, confirm five things:

  • Storage appears as its own line, not inside the closeout fee.
  • Physical and electronic storage are priced separately.
  • The retention period is stated in years, in writing, tied to the protocol and sponsor requirement.
  • The fee is annual, with the extension rate already agreed.
  • End-of-retention handling — return, transfer, or destruction, and who authorizes it — is written down.

None of this is difficult at signing. All of it is difficult at closeout, which is exactly why it belongs at the front of the negotiation.

How this works in practice

At Amavita Research, our Miami cardiovascular trial site, we care for more than 18,000 active cardiology patients, and our record includes zero FDA Form 483 findings. That record depends on records that stay complete, retrievable, and controlled for as long as they must be kept — not just while a study is enrolling. Treating storage as its own annual line, with the retention period agreed before signing, is a small budget discipline that protects both the site and the sponsor long after the last visit is done.

Julio G. Martinez-Clark is chief executive officer of Amavita Research Services, a Miami cardiovascular trial site, and chief executive officer of bioaccess, a first-in-human contract research organization.

Next step

Sponsors: see what Amavita Research can run

Amavita Research is a Miami cardiovascular trial site with 18,000+ active cardiology patients and zero United States Food and Drug Administration (FDA) Form 483 findings. See our site capabilities or talk with our sponsor team.

By Julio G. Martinez-Clark · Last updated November 17, 2026. This article is site-operations education and is not medical advice or a regulatory recommendation.